I. Rodríguez

Cyclophosphamide for Metastatic Cancer Combined with GM-CSF, Pegylated IFN, and Loaded with Autologous Tumor Lysates Pilot Clinical Trial of Type 1 Dendritic Cells

B. Sangro, I. Melero, S. Martín-Algarra, 2011 .

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

B. Sangro, I. Melero, S. Martín-Algarra, 2011, The Journal of Immunology.

Immune mechanisms mediating abscopal effects in radioimmunotherapy

I. Melero, M. Rodriguez-Ruiz, P. Lara, 2019, Pharmacology & therapeutics.

Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells

I. Melero, P. Berraondo, I. Rodríguez, 2017, Immunology and cell biology.

Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

B. Sangro, I. Melero, M. Rodriguez-Ruiz, 2014, Clinical Cancer Research.

Personalized Medicine and Imaging Serum Interleukin-8 Re fl ects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

B. Sangro, I. Melero, M. Rodriguez-Ruiz, 2014 .

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

I. Melero, M. Rodriguez-Ruiz, J. Pérez-Gracia, 2019, Molecular Cancer Therapeutics.

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

P. Wirtz, I. Melero, P. Berraondo, 2018, Oncoimmunology.